Karlheinz Schmelig
Director/Board Member chez PROSTATYPE GENOMICS AB
Provenance du réseau au premier degré de Karlheinz Schmelig
Entité | Type d'entité | Industrie | |
---|---|---|---|
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.
21
| Private Company | Investment Managers | 21 |
Public Company | Pharmaceuticals: Major | 16 | |
Public Company | Pharmaceuticals: Major | 15 | |
AYOXXA Biosystems GmbH
AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany.
12
| Private Company | Biotechnology | 12 |
TACALYX GmbH
TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.
8
| Holding Company | Pharmaceuticals: Generic | 8 |
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Cryotherapeutics SA
Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany.
6
| Holding Company | Medical Specialties | 6 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden.
6
| Holding Company | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Karlheinz Schmelig via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
2INVEST AG | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
MARNA BETEILIGUNGEN AG | Financial Conglomerates | Director/Board Member | |
SPARTA AG | Investment Managers | Chairman Director/Board Member | |
PANAMAX AG | Financial Conglomerates | Chairman | |
University of Freiburg | College/University | Undergraduate Degree Doctorate Degree | |
National University of Singapore | College/University | Corporate Officer/Principal | |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Universität zu Köln | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Ruhr-Universität Bochum | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Graduate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
HEIDELBERGER BETEILIGUNGSHOLDING AG | Financial Conglomerates | Director/Board Member | |
Scienion AG
Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Biotechnology | Chairman Chairman Chairman | |
Peppermint Holding GmbH
Peppermint Holding GmbH TextilesProcess Industries Peppermint Holding GmbH operates as a holding company with interests in textile industries. Its company portfolios include Zwickauer Kammgarn, Ertex Jacquard, and Color Textil. The company was founded by Ingeborg Neumann in 1997 and is headquartered in Berlin, Germany. | Textiles | Chief Investment Officer Corporate Officer/Principal | |
University of Duisburg-Essen | College/University | Doctorate Degree Undergraduate Degree | |
Philipps University of Marburg | College/University | Graduate Degree Doctorate Degree | |
Ludwig-Maximilians-Universität München | College/University | Masters Business Admin Doctorate Degree | |
The Hong Kong University of Science & Technology | College/University | Doctorate Degree | |
Delphi Unternehmensberatung AG
Delphi Unternehmensberatung AG Financial ConglomeratesFinance Delphi Unternehmensberatung AG provides investment services. The private company is based in Heidelberg, Germany. | Financial Conglomerates | Corporate Officer/Principal Chairman | |
m2p-labs GmbH
m2p-labs GmbH BiotechnologyHealth Technology m2p-labs GmbH manufactures and supplies micro bioreactors. The firm focuses on micro reaction and automated solutions for screening and bioprocess development. Its commercialized products are the BioLector and the FlowerPlate which provide an intelligent micro fermentation platform. The firm's technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments. The company was founded by Ingo Klammer, Carsten Müller, Mirko C. Hofmann and Frank Kensy on November 22, 2005 and is headquartered in Baesweiler, Germany. | Biotechnology | Chief Executive Officer | |
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
DIREVO Industrial Biotechnology GmbH
DIREVO Industrial Biotechnology GmbH Miscellaneous Commercial ServicesCommercial Services DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
BiognoSYS AG
BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Corporate Officer/Principal | |
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Riverside Europe Partners GmbH | Investment Managers | Private Equity Investor | |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Director/Board Member Chairman | |
AyoxxA Living Health Technologies Pte Ltd.
AyoxxA Living Health Technologies Pte Ltd. BiotechnologyHealth Technology AyoxxA Living Health Technologies Pte Ltd. engages in the research and development on biotechnology, life, and medical science. The company was founded by Andreas Schmidt in 2010 and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Founder | |
8sens.biognostic GmbH | Founder | ||
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
Kingstone Europe AG | Chairman | ||
coparion Komplementär GmbH
coparion Komplementär GmbH Investment ManagersFinance coparion Komplementär GmbH (coparion) is an independent venture capital firm founded in 2015. The firm is headquartered in Cologne, Germany, with another German office located in Cologne. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Alpha Cleantec AG | Chairman | ||
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman | |
4BASEBIO PLC | Biotechnology | Chief Executive Officer Director/Board Member | |
BIOFRONTERA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member | |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm specialized in seed investing. Founded in 2005, the firm is headquartered in Bonn, Germany. The firm manages venture capital funds raised from both the public and private sectors. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Shopgate GmbH
Shopgate GmbH Information Technology ServicesTechnology Services Shopgate GmbH develops and markets mobile shopping solutions. The firm's solution offerings encompass mobile optimized websites, mobile shopping applications, and tablet mobile commerce applications. It offers mobile marketing, social media, and direct customer communications tools. It also designs interfaces for shopping cart systems, payment methods, and tracking and analysis applications. The company was founded by Ortwin Kartmann, Andrea Anderheggen, and Dieter Kartmann in September 2009 and is headquartered in Butzbach, Germany. | Information Technology Services | Chief Executive Officer |
Statistiques
Internationale
Allemagne | 40 |
Suisse | 4 |
Singapour | 3 |
Etats-Unis | 3 |
France | 2 |
Sectorielle
Health Technology | 17 |
Consumer Services | 14 |
Finance | 13 |
Commercial Services | 3 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 240 |
Corporate Officer/Principal | 79 |
Private Equity Investor | 58 |
Chairman | 58 |
Chief Executive Officer | 46 |
Relations les plus connectées
Insiders | |
---|---|
Regina Hodits | 33 |
Gerald Heinz Möller | 29 |
Bengt Håkan Englund | 18 |
Klaus Schollmeier | 17 |
Heikki Lanckriet | 17 |
Aristotelis Nastos | 17 |
Daniel Karsberg | 17 |
Markus Hosang | 15 |
Karin Lergenmüller | 15 |
Farsin Yadegardjam | 14 |
Pawel Schapiro | 14 |
Helge Lubenow | 14 |
María del Pilar de la Huerta Martínez | 13 |
Franca Ruhwedel | 13 |
Maurice Buchbinder | 13 |
- Bourse
- Insiders
- Karlheinz Schmelig
- Connexions Sociétés